Orphenadrine Citrate
Product Images NDC 45865-363

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 45865-363). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (363 60)

Label for Orphenadrine Citrate ER Tablets 100mg, generic for Norflex, manufactured by Sandoz Inc., Princeton NJ. The label indicates 60 tablets per bottle with the NDC 45865-0363-60. Contains warnings about possible dizziness and drowsiness and instructions to take tablets multiple times daily. The label is issued by Medsource Pharmaceuticals.*

FDA Label Image

Chemical Structure (8120fe4d 7799 4de6 Bf2f F8c8721d11ae 01)

Chemical structure diagram of Orphenadrine Citrate. The image shows the molecular structures of the Orphenadrine and Citrate components with their respective molecular formulas and a molecular weight of 461.51.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.